about
Imaging-Based Treatment Adaptation in Radiation OncologyCorrelation between tumor oxygenation and 18F-fluoromisonidazole PET data simulated based on microvessel images.Automatic delineation of tumor volumes by co-segmentation of combined PET/MR data.A kinetic model for dynamic [18F]-Fmiso PET data to analyse tumour hypoxia.Analysis of pairwise correlations in multi-parametric PET/MR data for biological tumor characterization and treatment individualization strategies.Combined uptake of [18F]FDG and [18F]FMISO correlates with radiation therapy outcome in head-and-neck cancer patients.A model of reoxygenation dynamics of head-and-neck tumors based on serial 18F-fluoromisonidazole positron emission tomography investigations.Hypoxia dose painting by numbers: a planning study.Dose painting with IMPT, helical tomotherapy and IMXT: a dosimetric comparison.[Individualised radiotherapy on the basis of functional imaging with FMISO PET].Implementation of hypoxia imaging into treatment planning and delivery.Prospective evaluation of a hydrogel spacer for rectal separation in dose-escalated intensity-modulated radiotherapy for clinically localized prostate cancer.Personalized precision radiotherapy by integration of multi-parametric functional and biological imaging in prostate cancer: A feasibility study.Correlation of FMISO simulations with pimonidazole-stained tumor xenografts: A question of O2 consumption?Prognostic value of dynamic hypoxia PET in head and neck cancer: Results from a planned interim analysis of a randomized phase II hypoxia-image guided dose escalation trial.Functional imaging for radiotherapy treatment planning: current status and future directions-a review.PET/CT imaging for target volume delineation in curative intent radiotherapy of non-small cell lung cancer: IAEA consensus report 2014.Multi-modality functional image guided dose escalation in the presence of uncertainties.A strategy for multimodal deformable image registration to integrate PET/MR into radiotherapy treatment planning.Overlap of highly FDG-avid and FMISO hypoxic tumor subvolumes in patients with head and neck cancer.Comparison of DCE-MRI kinetic parameters and FMISO-PET uptake parameters in head and neck cancer patients.Comparison of [18F]-FMISO, [18F]-FAZA and [18F]-HX4 for PET imaging of hypoxia--a simulation study.Modelling and simulation of [18F]fluoromisonidazole dynamics based on histology-derived microvessel maps.ESTRO ACROP: Technology for precision small animal radiotherapy research: Optimal use and challenges.Molecular Imaging-Guided Radiotherapy for the Treatment of Head-and-Neck Squamous Cell Carcinoma: Does it Fulfill the Promises?Biologically adapted radiation therapy.Multi-centre calibration of an adaptive thresholding method for PET-based delineation of tumour volumes in radiotherapy planning of lung cancer.Geometric analysis of loco-regional recurrences in relation to pre-treatment hypoxia in patients with head and neck cancer.Distortion correction of diffusion-weighted magnetic resonance imaging of the head and neck in radiotherapy position.Multiple training interventions significantly improve reproducibility of PET/CT-based lung cancer radiotherapy target volume delineation using an IAEA study protocol.Longitudinal multi-parametric imaging in radiation oncology: boon or bane?NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy.Voxel-wise correlation of functional imaging parameters in HNSCC patients receiving PET/MRI in an irradiation setup.Robustness of quantitative hypoxia PET image analysis for predicting local tumor control.Modelling and simulation of the influence of acute and chronic hypoxia on [18F]fluoromisonidazole PET imaging.Potentials and challenges of diffusion-weighted magnetic resonance imaging in radiotherapyComparison of treatment plans for a high-field MRI-linac and a conventional linac for esophageal cancerAssessment of image quality of a radiotherapy-specific hardware solution for PET/MRI in head and neck cancer patientsRationale for Combining Radiotherapy and Immune Checkpoint Inhibition for Patients With Hypoxic TumorsComparison of different adjuvant radiotherapy approaches in childhood bladder/prostate rhabdomyosarcoma treated with conservative surgery
P50
Q28088626-1D4BC73B-4DB7-47D7-A662-16E7A3A09BD9Q30663793-AE42FC4C-8F6C-4EB5-8210-488B9107ED41Q30976704-422AFE6F-20A9-4003-B62D-626A5C255BC7Q30988968-6FA0BE29-4364-4643-907F-472F027087EFQ31044830-2994B319-C4C5-40D4-9D4F-ED49325CD5A0Q33254528-A45EB2C7-52A0-422A-A78A-4EB0CEBF80B0Q33280695-6DABE1E2-216B-4879-9EC9-CA3520964FA3Q33282382-60223D5F-9F49-4657-805E-3CCEE7D6510DQ33308827-376CF976-13F1-449E-8AD9-CA655C44B6BEQ33340409-0B545C6F-14A4-4BE7-94E7-419EC23C679BQ33613289-C11CCFF6-6798-436D-BFE8-B90DB5AE8711Q34556112-CA4997B3-FDA5-45A4-8EF2-B7E1BE30534BQ35937828-2874BA9E-9296-46DB-AF40-A361F39A1029Q36066409-9E4D93BD-1736-4D86-980F-984A902FF425Q36354479-DFFEBA4D-1225-4812-95DE-54D6F509FF71Q38397651-D70CDDE8-0EB0-4A0E-AF6F-9A7D67A3727EQ38419113-36790143-E46F-4005-9B0C-DF8410728559Q38420463-E015778A-4F3C-43EB-BFE8-C0F44428CF60Q38425300-FE34497A-FAAC-4741-A2A8-2FEBA3C1BADDQ38604187-5C2AF254-FD84-4BB9-AEB4-3AD16EB6ADC3Q38743120-44FBD7DA-A645-496E-8AB7-40C63DC8E62EQ40704400-201CB63D-3F99-4A19-ABC5-EFF488FA608AQ45087708-81F3660B-AD98-4751-8816-C90B54112D2DQ47264538-BF4B6855-0EA3-4F4B-B1E1-355C73649EFDQ47597760-D75CF2FE-DDD5-49BA-B79C-A871005C6EAEQ47966424-D8BD4743-B023-4CB4-A071-9EFBD2493B38Q47985232-61C0F02F-C82D-4E69-BE4E-55EBA04A5D4DQ48004858-A5EBCF11-3FF2-4A7C-92B6-409922E20297Q48565897-A9D8A051-BC5E-4B67-BAB2-21D4F31DF319Q48763632-5DC5194F-30F4-45B9-A953-F88C598DC34FQ50452212-A833E3CF-CA98-499B-8575-C9207A9E1259Q50938976-E011E7F7-5CE8-4FD6-B390-3C37DE7AAA40Q52643394-A03E38A2-FAD5-43F5-8054-800C3A3568C7Q52990174-127EBE80-A8B1-4B57-9BCC-C19D48B61DC0Q53172133-9FB46FCD-0B15-4A4B-A6D6-56A3822097BDQ57191662-61D67D34-FF53-4172-9804-1FC7BBEDAB0DQ58563924-45A6253F-AECD-48C7-A36F-22A8F49B8D62Q58774859-C863082C-9574-47A8-89E5-F1204D5D816BQ64102265-B3BB88C6-3F9D-4231-BF5B-2B559EB46EC9Q82257535-C84A07CD-D29B-4348-AD2C-AA60E3AEC06F
P50
description
German medical physicist
@en
deutsche medizinische Physikerin
@de
investigador
@es
wetenschapper
@nl
name
Daniela Thorwarth
@de
Daniela Thorwarth
@en
Daniela Thorwarth
@fr
Daniela Thorwarth
@nl
type
label
Daniela Thorwarth
@de
Daniela Thorwarth
@en
Daniela Thorwarth
@fr
Daniela Thorwarth
@nl
prefLabel
Daniela Thorwarth
@de
Daniela Thorwarth
@en
Daniela Thorwarth
@fr
Daniela Thorwarth
@nl
P227
P21
P227
P31
P496
0000-0003-1433-9315
P569
1977-01-01T00:00:00Z